FDA Clearance of Centric Medical Metatarsal Hemi Implant

By Julie A. Vetalice

Centric Medical received FDA 510(k) clearance to market its Metatarsal Hemi Implant system. The implant is intended to treat degenerative and post-traumatic arthritis with or without bone cement, in the presence of good bone stock, with the following clinical conditions: hallux valgus or hallux rigidus and an unstable or painful metatarsal/phalangeal joint.

Centric is the Foot & Ankle division of Life Spine, and has been established to treat disorders of distal extremities.

Sources: Centric Medical, LLC; ORTHOWORLD Inc.

Product Labels: Trauma Ankle/Foot/Toe

Tags: 510(k) Clearance, Regulatory